Episode Details

Our first story highlights Odin Medical’s FDA clearance for a cloud-based AI tool for detecting colorectal polyps during colonoscopies. The second story addresses updated estimates of atrial fibrillation (AF) prevalence in the U.S., revealing a significant increase in diagnosed cases, especially among younger, hypertensive, and diabetic patients. Finally, we explore new data on the the efficacy of Trastuzumab deruxtecan (T-DXd) in treating HER2+ metastatic breast cancer.